INDOLIZINE DERIVATIVES AS PHOSHOINOSITIDE 3-KINASES INHIBITORS
申请人:CHIESI FARMACEUTICI S.P.A.
公开号:US20150361100A1
公开(公告)日:2015-12-17
Compounds of formula (I), defined herein, inhibit phosphoinositide 3-kinases (PI3K) and are useful for the treatment of disorders associated with PI3K enzymes.